Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

P53, Ki67 and Cyclin A Immunohistochemical Staining as Predictors for Wilms' Tumour Aggressiveness and Recurrence

NCT04758455 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04758455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04758455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
P53, Ki67 and Cyclin A Immunohistochemical Staining as Predictors for Wilms' Tumour Aggressiveness and Recurrence
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Unknown status
Start date
February 14, 2021
Completion date
April 30, 2021
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

death, relapse, wilms tumor